Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate (Durezol) eye drops for macular edema and neovascular eye disease
jRCTs041180160Completed
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of difluprednate in macular edema and neovascular eye disease. Primary endpoints: macular thickness and visual acuity. Started Dec 2008; status: completed.
02
Drugs
difluprednate
03
Conditions
macular edemaneovascular eye disease
Beyond the preview
Go deeper on jRCTs041180160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180160.